Articles

Tim Chubb, chief investment officer at wealth management and advisory firm Girard, a Univest Wealth Division, flags tech and other “durable growth stories” in an uncertain economy.

Oil futures consolidate after rising more than 1% the previous session on fears of a more direct confrontation between Israel and Iran.

Five years after a fund’s collapse, the U.K. financial watchdog issued a warning notice to Neil Woodford and his fund management company, Woodford Investment Management.

Morgan Stanley said strong exports and a Beijing led investment push will see China’s economy grow faster than previously expected in 2024

Bond yields rose to fresh highs for the year as the prospects for multiple rate cuts in 2024 faded following data showing inflation picking up steam.

The French advertising giant said it saw a clear rebound in sales to tech companies following a slump that hit ad firms’ sales in 2023

Linking the trajectory of interest rate cuts in the U.K. too tightly to the U.S. is mistaken because British inflation will be stickier, according to a Bank of England monetary policymaker.

Marks & Spencer, the storied U.K. retailer, saw an upgrade to overweight at JPMorgan, as the bank said it’s the retailer demonstrating the biggest positive inflection out of the pandemic.

The Department of Justice on Wednesday accused drug maker Regeneron Pharmaceuticals Inc. of fraudulent practices related the pricing of its blockbuster vision-impairment drug Eylea, boosting its sales in the process.

Pricing power and lack of competition are driving Nvidia’s growth, but rivals are gaining traction.

The aerospace giant’s self-inflicted woes hold broader lessons on how to run a company.

Vertex Pharmaceuticals has agreed to acquire Alpine Immune Sciences for $4.9 billion in cash, bolstering its portfolio on kidney diseases as deals in biotechnology continue to heat up.